Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vvi4g0021 | ATGGCTATTAAACACGAGTTCCCTAGAAGCGGTAAGGAACTCAACGTCACCAAAATGCGGAAACCACCATTTTTATTTACCAAAATTCCATTCCCCGCTCTATTTCTCCTCCTCGTCTTCTCCTTAACCTTTCAAGTAATTTCCCAAAATCTAGATGCTGAACGATCAATCCTACTAGACGTTAAACAACAACTGGGCAATCCACCGTCACTCCAATCGTGGAATTCCTCATCCTCGCCCTGTGATTGGTCGGAAATTACATGCATCGACAATATCGTCACTGAAATTTCACTCAGCTACAAGACCATCACAAAGAAAATTCCAGCCAGAATTTGTGACCTCAAGAACCTAATCGTACTTGACGTCTCCTACAATTACATTCCAGGCGAGTTCCCGGATATTCTCAATTGCTCTAAGCTCGAATATCTCCTCTTGTTGCAAAACTCCTTCGTGGGTCCAATTCCAGCTGATATTGATCGACTTTCACGTCTCCGGTACCTAGACCTCACCGCAAACAACTTCTCTGGAGATATTCCCGCAGCAATTGGGCGGCTACGGGAGCTGTTCTACTTGTTTATGGTTCAAAATGAGTTCAACGGCACCTGGCCAACAGAGATTGGTAATTTGGCAAATCTTGAACAATTGGCCATGGCCTATAATGACAAATTCCGGCCTTCAGCCCTTCCAAAGGAGTTTGGCGCATTGAAGAAGCTGAAATTTCTGTGGATGACGGAGGCGAATTTGATCGGCGAAATACCGAAGAGCTTCAACAATCTATCGAGTCTGGAACGCTTGGACCTCTCACTCAACGAATTGAATGGTACGATCCCGGTAGGCATGCTTACGTTGAAGAATTTGACCTATTTGTATTTATTCTGTAATAGATTGTCAGGCCGCGTTCCTTCATCGATAGAAGCTTTCAACTTGAAAGAAATTGATCTTTCCGACAACCATTTGACGGGGCCGATACCAGCAGGTTTCGTGAAGCTACAAAATTTGACATGTTTGAATCTTTTTTGGAATCAGTTGTCAGGAGAGATACCAGCAAATATAAGCCTCATTCCTACACTTGAAACCTTCAAAGTTTTTAGCAATAAATTGAGTGGAGTTTTGCCCCCAGCATTTGGCCTTCATTCGGAGCTCAAATTCTTTGAGATTTTTGAGAATAAACTAAGCGGGGAACTACCGCAACATTTATGCGCTAGGGGAACTTTGCTTGGAGTGATTGCTTCCAACAATAATCTCAGCGGAGAAGTGCCCAAGTCCCTCGGGAATTGCAGAAGTTTGCTCACCATTCAGGTTTCCAACAATCGCTTTTCAGGCGAGATTCCTTCTGGCATCTGGACATCCCCGGGCATGGTATCGGTGATGTTAGCTGGAAATTCATTCTCGGGGGCACTTCCAAGTAGATTGGCAAGGAATTTGTCCAGAGTGGATATCAGTAACAACAAGTTTTCTGGTCCAATTCCTACTGAAATCTCTTCTTGGATGAAAATAGGTGTTCTTAATGCCAACAACAATATGTTGTCAGGAAAAATTCCAGTGGAATTGACCAGTCTTTGGAACATCTCTGTTCTGTTGCTTGATGGGAATCAATTCTCGGGTGAACTTCCATCCCAGATCATCTCATGGAAGTCACTCACTAATTTGAATCTCTCAAGAAACAAACTGTCAGGCCTAATTCCCAAGGCATTAGGTTCTTTACCTAGCCTTACTTACCTCGACCTGTCAGAAAACCAGTTCTTAGGTCAAATTCCTTCTGAACTCGGTCATTTGAAGCTTAATATCCTCAATCTTTCGTCCAACCAACTCTCTGGGTTGGTCCCCTTTGAGTTTCAAAATGCAGCATACAATTACAGTTTCTTGAACAATCCCAAACTGTGTGTCAATGTTCCCACTCTGAACCTCCCTAGATGTGATGCCAAACCCGTTGACTCCTACAAATTGTCAACCAAATATCTTGTTATGATCCTAATTTTCGCTCTATCTGGTTTCCTAGCTGTTGCCTTCTTTACCCTGTTCATGGTTCGACACTATCACAGGAAGAATCATAGTCGAGACCAAACAAATTGGAAGCTTACTCCATTCCAAAATCTGGATTTCGATGAACAGAACATATTGTTCGGTTTGACAGAAAATAATTTGATCGGACGTGGTGGGTCAGGGAAAGTATACCGAATTGCTAATGACCGTTCTGGTGAAATCTTTGCTGTTAAAATGATTTGTAACAACGGGAGATTGGATCACAAGCTTCAGAAACCATTCATAGCAAAAGACGAGATATTGGGCACCTTACACCATTCCAATATAGTGAAGTTGTTGTGCTGCATATCAAATGAAACCACAAGTCTTCTTGTTTATGAGTACATGGAGAACCAAAGTTTGGATAGATGGCTTCATGGGAAGAAGCAGAGAACATCGTCCATGACAAGTTCAGTTCATAACTTCGTCTTGGATTGGCCAACAAGGTTGCAGATTGCCATCGGAGCTGCAAAAGGCCTACGCCACATGCATGAATACTGTTCTGCCCCGATCATACATCGAGATGTAAAGTCCAGCAACATCTTACTAGACGCTGAGTTCAACGCGAAAATTGCAGATTTTGGATTAGCCAAGATGTTGGTCAAGCAAGGAGAGCCTGACACCATGTCAGGAGTTGCAGGCTCTTACGGATATATTGCCCCCGAGTATGCTTATACAACAAAGGTGAACGAGAAGATTGATGTATATAGCTTTGGAGTAGTTCTGCTTGAGCTGGTGACGGGGAGAGAACCCAACAGCGAGCACATGTGCCTTGTAGAATGGGCATGGGATCAGTTTAGAGAAGGGAAAACCATTGAGGAAGTGGTGGATGAGGAGATCAAGGAACAATGTAACAGAGCACAAGTGACCACTCTCTTCAATCTAGGCCTCATGTGCACTACCACATTACCATCCACTAGGCCAACAATGAAGGAGGTTTTGGAAATTCTTCGACAGTGCAATCCTCAGAAGGACCATGGAAGAAAGAAAAAGGACCATGAAGCTGCACTCGAACATACATCGAGATGTAAAGTCCAGCAACATCTTACTAGACGTTGA | 3081 | 0.4333 | MAIKHEFPRSGKELNVTKMRKPPFLFTKIPFPALFLLLVFSLTFQVISQNLDAERSILLDVKQQLGNPPSLQSWNSSSSPCDWSEITCIDNIVTEISLSYKTITKKIPARICDLKNLIVLDVSYNYIPGEFPDILNCSKLEYLLLLQNSFVGPIPADIDRLSRLRYLDLTANNFSGDIPAAIGRLRELFYLFMVQNEFNGTWPTEIGNLANLEQLAMAYNDKFRPSALPKEFGALKKLKFLWMTEANLIGEIPKSFNNLSSLERLDLSLNELNGTIPVGMLTLKNLTYLYLFCNRLSGRVPSSIEAFNLKEIDLSDNHLTGPIPAGFVKLQNLTCLNLFWNQLSGEIPANISLIPTLETFKVFSNKLSGVLPPAFGLHSELKFFEIFENKLSGELPQHLCARGTLLGVIASNNNLSGEVPKSLGNCRSLLTIQVSNNRFSGEIPSGIWTSPGMVSVMLAGNSFSGALPSRLARNLSRVDISNNKFSGPIPTEISSWMKIGVLNANNNMLSGKIPVELTSLWNISVLLLDGNQFSGELPSQIISWKSLTNLNLSRNKLSGLIPKALGSLPSLTYLDLSENQFLGQIPSELGHLKLNILNLSSNQLSGLVPFEFQNAAYNYSFLNNPKLCVNVPTLNLPRCDAKPVDSYKLSTKYLVMILIFALSGFLAVAFFTLFMVRHYHRKNHSRDQTNWKLTPFQNLDFDEQNILFGLTENNLIGRGGSGKVYRIANDRSGEIFAVKMICNNGRLDHKLQKPFIAKDEILGTLHHSNIVKLLCCISNETTSLLVYEYMENQSLDRWLHGKKQRTSSMTSSVHNFVLDWPTRLQIAIGAAKGLRHMHEYCSAPIIHRDVKSSNILLDAEFNAKIADFGLAKMLVKQGEPDTMSGVAGSYGYIAPEYAYTTKVNEKIDVYSFGVVLLELVTGREPNSEHMCLVEWAWDQFREGKTIEEVVDEEIKEQCNRAQVTTLFNLGLMCTTTLPSTRPTMKEVLEILRQCNPQKDHGRKKKDHEAALEHTSRCKVQQHLTRR* | 1027 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vvi4g0021 | 1026 | MobiDBLite | consensus disorder prediction | 998 | 1019 | - | - | |
Vvi4g0021 | 1026 | ProSitePatterns | Protein kinases ATP-binding region signature. | 716 | 739 | IPR017441 | GO:0005524 | |
Vvi4g0021 | 1026 | Gene3D | Transferase(Phosphotransferase) domain 1 | 790 | 1020 | - | - | |
Vvi4g0021 | 1026 | FunFam | Kinase family with leucine-rich repeat domain-containing protein | 790 | 1008 | - | - | |
Vvi4g0021 | 1026 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 211 | 993 | - | - | |
Vvi4g0021 | 1026 | Gene3D | Phosphorylase Kinase; domain 1 | 694 | 789 | - | - | |
Vvi4g0021 | 1026 | ProSiteProfiles | Leucine-rich repeat profile. | 593 | 614 | IPR001611 | GO:0005515 | |
Vvi4g0021 | 1026 | Gene3D | Ribonuclease Inhibitor | 51 | 223 | IPR032675 | - | |
Vvi4g0021 | 1026 | Gene3D | Ribonuclease Inhibitor | 473 | 642 | IPR032675 | - | |
Vvi4g0021 | 1026 | FunFam | Receptor-like protein kinase HSL1 | 690 | 789 | - | - | |
Vvi4g0021 | 1026 | FunFam | Receptor-like protein kinase HSL1 | 51 | 205 | - | - | |
Vvi4g0021 | 1026 | SMART | LRR_typ_2 | 330 | 354 | IPR003591 | - | |
Vvi4g0021 | 1026 | SMART | LRR_typ_2 | 568 | 592 | IPR003591 | - | |
Vvi4g0021 | 1026 | SMART | LRR_typ_2 | 593 | 614 | IPR003591 | - | |
Vvi4g0021 | 1026 | SMART | LRR_typ_2 | 161 | 185 | IPR003591 | - | |
Vvi4g0021 | 1026 | SMART | LRR_typ_2 | 544 | 567 | IPR003591 | - | |
Vvi4g0021 | 1026 | SMART | LRR_typ_2 | 259 | 283 | IPR003591 | - | |
Vvi4g0021 | 1026 | Pfam | Leucine Rich Repeat | 308 | 330 | IPR001611 | GO:0005515 | |
Vvi4g0021 | 1026 | MobiDBLite | consensus disorder prediction | 998 | 1026 | - | - | |
Vvi4g0021 | 1026 | SUPERFAMILY | L domain-like | 411 | 628 | - | - | |
Vvi4g0021 | 1026 | FunFam | Uncharacterized protein | 352 | 642 | - | - | |
Vvi4g0021 | 1026 | SUPERFAMILY | L domain-like | 62 | 399 | - | - | |
Vvi4g0021 | 1026 | Pfam | Leucine rich repeat N-terminal domain | 52 | 88 | IPR013210 | - | |
Vvi4g0021 | 1026 | ProSiteProfiles | Protein kinase domain profile. | 710 | 998 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi4g0021 | 1026 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 845 | 857 | IPR008271 | GO:0004672|GO:0006468 | |
Vvi4g0021 | 1026 | SMART | serkin_6 | 710 | 990 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi4g0021 | 1026 | SUPERFAMILY | Protein kinase-like (PK-like) | 709 | 992 | IPR011009 | - | |
Vvi4g0021 | 1026 | Pfam | Protein kinase domain | 712 | 989 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi4g0021 | 1026 | Pfam | Leucine rich repeat | 543 | 581 | IPR001611 | GO:0005515 | |
Vvi4g0021 | 1026 | FunFam | Uncharacterized protein | 219 | 306 | - | - | |
Vvi4g0021 | 1026 | Gene3D | Ribonuclease Inhibitor | 224 | 472 | IPR032675 | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vvi4g0021 | Vvi-Chr4 | 227664 | 239766 | Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vvi4g0021 | 41 | 1011 | Receptor kinase-like Gene Family | AT5G25930 | 54.555 | 0.0 | 1019 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Vvi4g0021 | Pkinase | 7.9e-46 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vvi4g0021 | K00924 | - | vvi:100257733 | 1994.93 |